Natural Product Nitric Oxide Chemistry: New Activity of Old Medicines by Jiang, Hong et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 873210, 9 pages
doi:10.1155/2012/873210
Review Article
Natural Product Nitric Oxide Chemistry:
NewActivity ofOldMedicines
Hong Jiang,1 Ashley C.Torregrossa,1 DeepaK.Parthasarathy,1 andNathan S.Bryan1,2
1Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine,
The University of Texas Health Science Center at Houston, 1825 Pressler Street, Houston, TX 77030, USA
2Department of Integrative Biology and Pharmacology, The University of Texas Graduate School of Biomedical Sciences at Houston,
The University of Texas Health Science Center at Houston, 1825 Pressler Street, Houston, TX 77030, USA
Correspondence should be addressed to Nathan S. Bryan, nathan.bryan@uth.tmc.edu
Received 14 October 2011; Accepted 19 January 2012
Academic Editor: Ka Kit Hui
Copyright © 2012 Hong Jiang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The use of complementary and alternative medicine (CAM) as a therapy and preventative care measure for cardiovascular diseases
(CVD) may prove to be beneﬁcial when used in conjunction with or in place of conventional medicine. However, the lack of
understanding of a mechanism of action of many CAMs limits their use and acceptance in western medicine. We have recently
recognized and characterized speciﬁc nitric oxide (NO) activity of select alternative and herbal medicines that may account for
many of their reported health beneﬁts. The ability of certain CAM to restore NO homeostasis both through enhancing endothelial
production of NO and by providing a system for reducing nitrate and nitrite to NO as a compensatory pathway for repleting NO
bioavailability may prove to be a safe and cost-eﬀective strategy for combating CVD. We will review the current state of science
behind NO activity of herbal medicines and their eﬀects on CVD.
1.Introduction
Complementary and alternative medicine (CAM) is the term
formedicalproductsandpracticesthatarenotapartofstan-
dard care. There is generally a lack of understanding of their
mechanisms of action and/or the active compounds. Rigor-
ous, well-designed clinical trials for many CAM therapies are
often lacking; therefore, the safety and eﬀectiveness of many
of these types of therapies are uncertain and as a result are
not recognized as mainstream therapy. However, Traditional
Chinese Medicine (TCM) is a form of CAM that remains
the primary form of medicine throughout a large portion
of Asia and Asian communities in the rest of world with a
long history of safety and eﬃcacy in a number of diﬀerent
diseases. In fact, one could argue that TCM is the earliest
form of CAM. Deﬁning CAM here in the USA is diﬃcult
because the ﬁeld is very broad and constantly changing. The
National Institutes of Health now has a dedicated Center for
Complementary and Alternative Medicine (NCCAM) due to
the growing popularity of such approaches to ensure safety
and promote rigorous clinical trials to demonstrate eﬃcacy.
NCCAM deﬁnes CAM as a group of diverse medical and
health care systems, practices, and products that are not gen-
erally considered part of conventional medicine, as practiced
by medical doctors and their allied health professionals. The
boundaries between CAM and conventional medicine are
not absolute, and speciﬁc CAM practices may, over time,
become widely accepted. Complementary medicine refers
to use of alternative treatments together with conventional
medicine, such as using acupuncture or herbal medicines
in addition to usual care to help with disease management.
Most use of CAM by Americans is complementary. Alterna-
tive medicine refers to use of CAM in place of conventional
medicine. Integrative medicine combines treatments from
conventional medicine and CAM for which there is some
high-quality evidence of safety and eﬀectiveness. It is also
called integrated medicine. Since many CAM-based thera-
pies are derived from TCM, we will provide a brief historical
account behind the theory of TCM, and how this has now
been integrated into CAM approaches here in the USA.
TCM has long been used as a major health care system in
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is typically referred to as CAM. TCM has its origin in ancient
Taoist philosophy, which views a person as an energy system
in which the body, mind, and spirit are uniﬁed into one
wheninharmonyandaredisruptedindisease.TCMpractice
treats the patient as a whole, not as a part, and it emphasizes
a holistic approach that attempts to bring the mind, body,
and spirit into harmony. TCM theory is extremely complex
and originated thousands of years ago through meticulous
observation of nature, the cosmos, and the human body. In
TCM theory, imbalance between yin and yang is a summa-
tion of all kinds of basic disease and disorders. There is a
growing and sustained interest in CAM and TCM fueled by
a combination of factors including recognition of the bene-
ﬁts, dissatisfaction with and ineﬀectiveness of traditional
Western medicines, increasing commitment to holistic care,
skepticism regarding adverse side eﬀects of drugs, and in-
creasing evidence for the personalized nature of various
combinations of herbs for speciﬁc disorders [1]. The use of
TCM is increasing in Western nations, mostly among people
of Southeast Asian origin. Patients who use TCM in Western
countries report that the main reason for using it is that
TCM is a “more natural” and potentially safer alternative in
the treatment of chronic illness than pharmaceutical drugs
or surgery [1]. Of the approximately 500 herbs that are
in use today, 50 or so are very commonly used alone or
in combination. Rather than being prescribed individually,
single herbs are combined into formulas that are designed
to adapt to the speciﬁc needs of individual patients. A herbal
formulacancontainfrom3to25herbs.Eachherbhasoneor
more of the four ﬂavors/functions and one of ﬁve “temper-
atures” “ ” (pronounced “chi”) (hot, warm, neutral, cool,
cold). Herbal formulations work to balance the body from
the inside out. Traditional herbal medicines include herbs,
herbal materials, herbal preparations, and processed herbal
products that contain parts of plants or other plant materials
asactiveingredients,whichassistwithstrengtheningthevital
energies (chi), blood, and ﬂuids internally. They are typically
administered as tablets, pills, elixirs, soups, liquid extracts,
and teas and broadly classiﬁed as dietary supplements here
in the USA. There are a number of published reports on the
association of TCM and NO-related eﬀects [2, 3]. Recently,
there are increased interests in the role for NO system in reg-
ulation of cardiovascular function by TCM used commonly
forcardiovasculardisorders. Recognizing and understanding
NO activity of TCM may help explain centuries of treatment
eﬃcacy in a number of diseases and highlight new treatment
options for conditions of NO insuﬃciency.
2. CurrentGlobal Markets for CAM
A 2002 survey of US adults 18 years and older conducted
by the National Center for Health Statistics (CDC) and the
NCCAM indicated that 74.6% had used some form of CAM,
62.1% had done so within the preceding 12 months, 54.9%
used CAM in conjunction with conventional medicine, and
14.8% sought care from a licensed or certiﬁed practitioner
suggesting that most individuals who use CAM prefer to
treat themselves [4]. The industry of alternative and comple-
mentary medicines broadly classiﬁed as dietary supplements
is expected to be $250 billion by 2016 worldwide. In 2004, a
surveyofnearly1,400UShospitalsfoundthatmorethanone
infouroﬀeredalternativeandcomplementarytherapiessuch
as acupuncture, homeopathy, and massage therapy. Herbal
treatmentsarethemostpopularformoftraditionalmedicine
or CAM and are highly lucrative in the international market-
place. Annual revenues in Western Europe reached $5 billion
in 2003-2004. In China, sales of products totaled $14 billi-
onin2005.HerbalmedicinerevenueinBrazilwas$160milli-
on in 2007, according to WHO Fact Sheet no. 134, 2008.
Therefore,thisindustryandtypeofhealthcarecannolonger
be ignored. In order to better understand the mechanism
of action and the safety proﬁle of herbal remedies, more re-
search and resources are needed. Identifying physiological
systems or molecular targets that may be aﬀected by TCM
will help propel the ﬁeld and industry forward and create a
better safety and eﬃcacy proﬁle of certain CAMs.
3. Production andRegulation of NO in the
CardiovascularSystem
Appropriate levels of NO production are critical in tissue
blood perfusion and protection of cardiovascular tissues
against ischemia and infarction. NO is endogenously gener-
ated from the amino acid L-arginine and molecular oxygen
in reactions catalyzed by a family of enzymes called NO syn-
thases (NOS). There are three mammalian NOS iso-
forms: neuronal (nNOS), endothelial (eNOS), and inducible
(iNOS). They share 50–60% homology at the amino acid
level [5]. Under physiological conditions, the dominant NOS
isoforminthevasculatureiseNOS,whichratherthanbeinga
constitutive enzyme as was ﬁrst suggested is dynamically reg-
ulated at the transcriptional, posttranscriptional, and post-
translational levels [6]. Endothelial dysfunction arises from
downregulation of eNOS expression and activity and uncou-
pling of NOS generating free radicals [7]. We now recognize
and appreciate that the endothelial production of NO
declines progressively withageandcanbe furtherreducedby
poordietandlifestyle[8–10].Thisbecomesthebasisforend-
othelial dysfunction and the etiology of a number of CVD-
related symptoms. Restoring endogenous production of NO
or providing an exogenous source of NO would be an attrac-
tive therapeutic option if this intervention could slow down
the progression of endothelial dysfunction and reduce the
risk of CVD.
Recently, an alternative pathway for NO generation was
discovered, wherein the inorganic anions nitrate and nitrite,
most often considered inert end products from NO oxida-
tion,canbereducedbacktoNOandotherbioactivenitrogen
oxide species.This nitrate-nitrite-nitric oxide pathwayis reg-
ulateddiﬀerentlythantheclassicL-arginine-nitricoxidesyn-
thasepathwayasshowninFigure 1,anditisgreatlyenhanced
during hypoxia and acidosis. Nitrite and nitrate have now
movedtotheforefrontofNObiology[11]withthediscovery
that it represents a major storage form of NO in both blood
and tissues [12]. Dietary nitrite and nitrate have been shownEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: A schematic presentation of a mammalian nitric oxide (NO) cycle. NO is generated by nitric oxide synthases (NOS) in most
cells of the body and participates in regulation of numerous physiologic functions. The bioactivity of nitric oxide is partly regulated by its
rapid oxidation to nitrite (NO2
–) or, in the presence of oxyhemoglobin, to nitrate (NO3
–). Nitrate is the predominant nitric oxide oxidation
product in the circulation. In our bodies, nitrate can undergo reduction to nitrite, and this process is strongly dependent on oral commensal
bacteria. In blood and tissues, nitrite can be further reduced to nitric oxide and other bioactive nitrogen oxides. There are several enzymatic
and nonenzymatic routes that can catalyze this reduction, most of which are greatly enhanced under hypoxic conditions. This mammalian
nitrogen cycle can be fueled by the diet because vegetables contain high amounts of inorganic nitrate.
to protect from tissue injury and restore NO homeostasis
in eNOS￿/− mice [13, 14]. Orally administered nitrite also
attenuates cardiac allograft rejection in rats [15]. Nitrate is
the primary anion present in green leafy vegetables and has
been hypothesized to account for some of the health bene-
ﬁ t so fv e g e t a b l e s[ 16]. There are a number of published
studies to support this hypothesis via its reduction to nitrite
[17, 18]. The nitrate-nitrite-nitric oxide pathway is boosted
by dietary intake of nitrate. Dietary nitrate supplementation
has been shown to reduce diastolic blood pressure [19], inhi-
bit platelet aggregation, and protect the heart from ischemia-
reperfusion injury [20]. This pathway may also explain the
eﬀectsofcertainethnicdiets.DietarynitrateinJapanesefood
was shown to lower blood pressure in healthy volunteers
[21]. It is well established that diets rich in fruit and vege-
tables (e.g., the Mediterranean diet) protect against develop-
ment of cardiovascular disease [22–24] and these data may
p r o v i d ee v i d e n c ea st ow h y .
The ﬁrst metabolic activation step for this pathway re-
quires commensal bacteria to reduce nitrate to nitrite [25].
There are a number of endogenous systems in mammals
capable of reducing nitrite to NO although most are very in-
eﬃcientandinhibitedbyoxygen[26].Forthissystemtopro-
ceed, there must be enough substrate for reduction and the
necessary bacteria and reductive machinery to reduce nitrate
all the way down to NO. Dietary and enzymatic sources of
nitrate are a potentially large source of nitrite and ultimately
NO in the human body. The nitrite converted from nitrate
by oral bacteria disproportionates with formation of NO
afterenteringtheacidicenvironmentofthestomach,helping
to reduce gastrointestinal tract infection, increase mucous
barrier thickness and increase gastric blood ﬂow [27]. In
addition to the simple protonation of nitrite in the stoma-
ch, there are several enzymatic pathways for conversion of
systemic nitrite to NO and other bioactive nitrogen species.
Hemoglobin, myoglobin, neuroglobin, xanthine oxidoredu-
ctase, aldehyde oxidase, carbonic anhydrase, and mitochon-
drial enzymes have all been identiﬁed with having a role in
nitrite bioactivation [28]( Figure 1). However, all of these
pathways are grossly ineﬃcient along the physiological oxy-
gen gradient with oxygen being a potent inhibitor of nitrite
reduction [26, 29]. Therefore, for this system to generate
enough bioactive NO, there must be suﬃcient nitrate and
nitrite available for this ineﬃcient reduction. A consequence
of endothelial dysfunction is reduced blood and tissue levels
of nitrite available for reduction [14, 30], further comprising
this alternative NO pathway. Since most of the TCMs are
herbalextracts,weinitiallythoughttheymaybegoodsources
ofnitriteandnitrate.Alsoantioxidantsandpolyphenolshave
been shown to eﬀectively reduce nitrite to NO [31]. This
combination of nitrite, nitrate and polyphenols could pro-
videthenasystemforrepletingNOhomeostasis.Werecently
testedandconﬁrmedthishypothesis[32]andﬁndthatselect
herbal extracts contain high amounts of nitrate and also the
capacity to reduce nitrite to NO. If our current paradigm is
true, then restoration of NO homeostasis may be a primary
targetfortreatingandpreventingCVD.Ashortreviewofthis
paradigm follows.4 Evidence-Based Complementary and Alternative Medicine
4. NO Insufﬁciency Is the Root Cause of CVD
CVD is a group of disorders including congestive heart
failure (CHF) and ischemic heart disease that are becoming
the leading cause of morbidity and mortality in the world
[33, 34]. CVD can result from a quantitative or functional
NO deﬁciency that can limit NO-dependent signal transduc-
tion pathways to the detriment of normal cellular function.
NO formation by endothelial NO synthase (eNOS) plays an
important role in the regulation of vasomotor tone in the
pulmonary and systemic vascular beds [35–37]. However,
NO generation by eNOS may be rapidly depleted in ischemic
conditions, since eNOS is dependent upon the availability of
oxygen [38, 39]. Loss of endogenous NO activity has a num-
ber of detrimental actions, most notably, vasoconstriction,
increased activity and adherence of platelets, and accumu-
lation of inﬂammatory cells at sites of endothelial damage.
Endothelial damage is associated with most forms of CVD.
NOpossessesanumberofphysiologicalpropertiesthatmake
it a potent cardioprotective-signaling molecule [40]. First,
NO is a potent vasodilator [41] ,w h i c ha l l o w sf o rr e g u l a t i o n
of blood ﬂow and essential perfusion of tissue as needed.
Secondly, NO reversibly inhibits mitochondrial respiration
[42]. The inhibition of mitochondrial respiration during an
ischemia-reperfusion event such as heart attack or stroke
counterintuitively leads to a decrease in mitochondrial-
driven injury by extending the zone of adequate tissue
cellular oxygenation away from vessels [43]. Thirdly, NO
is a potent inhibitor of neutrophil adherence to vascular
endothelium [44]. Neutrophil adherence is an important
event initiating further leukocyte activation and superoxide
radical generation, which in turn leads to injury to the
endothelium and perivascular myocardium in the ischemic
heart [45]. Fourth, NO also prevents platelet aggregation
[46], which together with the antineutrophil actions of NO
attenuates capillary plugging [47]. Finally NO inhibits apop-
tosis directly or indirectly by inhibiting caspase-3-like acti-
vation via a cGMP-dependent mechanisms and/or through
protein S-nitrosylation [48, 49]. Without suﬃcient NO
production, the body loses its ability to regulate and control
normal vascular function. Therefore, strategies designed to
enhance NO production and reduce reactive oxygen species
productionwilllikelylimitinjuryandimproverecoveryfrom
CVDorperhapsevenpreventonsetandprogressionofCVD.
5. Therapeutic Effects andNitric Oxide
Bioactivity of TCM
Traditional herbal medicines used for thousands of years in
Asia and other regions have been proven eﬀective in certain
cardiovascular disorders. Some of the herbal medicines
have profound NO bioactivity primarily due to the nitrate-
nitrite-NO reduction pathway [32]. They contain very large
amounts of nitrate/nitrite in the extracts given to patients
[32]. The described beneﬁts of these ancient medications
may be attributed to their inherent nitrate/nitrite content
combined with their robust nitrate/nitrite reductase activity
to generate NO independent of the L-arginine-NO pathway
[14, 26, 32, 50]. The ﬁrst use of nitrate for treatment of pa-
tients with symptoms that appears to be angina was des-
cribed in an 8th century Chinese manuscript uncovered at
the Buddhist grotto of Dunhuang [51]. The patients were
instructed to take Xiao Shi Xiong Huang San, hold it under
the tongue for a time, and then swallow the saliva. The sig-
niﬁcance of the instructions is that under the tongue, even
in a healthy mouth, nitrate-reducing bacteria convert some
of the nitrate into nitrite. Therefore, if the patient follows
the physician’s instructions fully, he or she will be taking
nitrite, known to be eﬀective in alleviating pain resulting
fromangina.Chinesephysiciansintraditionalmedicinehave
more recently tested the therapeutic eﬀects of Xiao Shi Xio-
ng Huang San (the Nitrum and Realgar Powder), one of the
Dunhuang prescriptions, on angina pectoris caused by coro-
nary heart disease. Compared to nitroglycerin, Xiao Shi
XiongHuangSanshowedmuchhighereﬃcacyandimprove-
ment in a clinical trial of 61 patients [52]. Recently, the
research results demonstrate that certain TCM increased NO
release in rat vascular endothelial cells under hypoxia [53].
Puriﬁed ginsenoside Rg1 enhanced the production of NO
from IFN-gamma-activated-macrophage cells RAW 264-7
[54]. Mu-Fang-Ji-Tang (TJ-36), a traditional Chinese her-
bal medicine, is made from four natural traditional Chi-
nese drugs: Panax ginseng radix, Cinnamomum cassia,
Sinomenum acutum, and Gypsum ﬁbrosum, which is said
to have been used for more than 1800 years to treat heart
failureinChina.RecentstudieshaveshownthatMu-Fang-Ji-
Tang (TJ-36) had protective eﬀects against myocardial injury
inamurinemodelofcongestiveheartfailureinducedbyviral
myocarditis [55]. Our studies have provided convincing evi-
dence that many of these TCM contain signiﬁcant amounts
of nitrate and nitrite and also active nitrite reductase activity
in certain herbs known to have protective or therapeutic
beneﬁts to patients with CVD (Table 1), such as the Danshen
Root (radix salviae miltiorrhizae), Sanchi (radix notogin-
seng), and Hongshen (radix ginseng) [32]. These herbs, with
speciﬁc indications for cardiovascular disease can generate
NO from nitrite, and relax blood vessels. The therapeutic
beneﬁts of these herbal medicines are providing an alterna-
tive source of NO to patients that may be unable to make NO
from L-arginine owing to endothelial dysfunction. There is
an endogenous nitrite reductase activity in animal tissues,
such as the liver and aorta, but this inherent biological
capacity is low (around 1pmoL/mg protein). The reductase
activity in some of these herbal medicines may exceed that
detected in the animal tissues [32]. It is estimated that the
increased reductase activity may occur by orders of magni-
tude, almost 1000 times higher than endogenous production
of NO. This would equate to 300nmoles per day of NO from
a single herbal preparation. The average NO production in
the human body (70kg) is 1.68mmoL NO per day (based
on an NO production rate of 1μmoL/kg/h). By supplying
the exogenous nitrate/nitrite and reductase activities, herbal
medicines oﬀer an alternative therapeutic strategy to combat
or treat any condition related to NO insuﬃciency including
heart disease and hypertension. Maintaining NO homeosta-
sis requires the repletion of nitrite and nitrate through which
the ability to generate NO can be restored to compensateEvidence-Based Complementary and Alternative Medicine 5
Table 1: The measurements of nitrite, nitrate, nitroso, nitrite reductase activity in several TCM herbs commonly used for CAD.
Chinese name English name Latin name Indication Nitrite
(ng/g)
Nitrate
(mg/g)
Nitroso
(nmoL/g)
NO production
(pmol/mg)
DanShen Danahen Root Radix Salviae
Miltiorrhizae CAD 330 12000 120 7
GuaLou Snakegourd Fruit Fructus Trichosanthis CAD, acute MI,
Hyperlipidemia 260 278 120 46
XieBai Longstamen Onion
Bulb Bulbus Allii Macrostemi CAD, acute MI,
Hyperlipidemia 150 530 842 134
SanChi Sanchi Radix Notoginseng CAD 210 2069 73 13
RuXiang Frankincense Resina Olibani Hypertension 980 61 3210 72
ChiShao Red Peony Root Radix Paeonia Rubra CAD 120 37 450 255
HongSheng Ginseng Radix Ginseng Heart failure, CAD 300 243 76 360
BingPiang Borneol Borneolum Syntheticum
Increase other herb’s
function for CAD or
brain disease
120 2.99 6 45
TianRanBingPiang Borneol Cinnamomum
Increase other herb’s
function for CAD or
brain disease
160 2.39 0 875
for the inability of the endothelium to convert L-arginine
to NO in coronary heart disease. This concept has recently
beentestedthroughthedevelopmentofarationallydesigned
dietary supplement with natural products selected for their
NO activity based on their nitrite, nitrate content, and an
oxygen independent nitrite reductase. In a double-blinded
placebo-controlled study in patients over the age of 40 with
at least 3 cardiovascular risk factors, this type of technology
was found to signiﬁcantly restore plasma levels of nitrite and
nitrate, reduce triglycerides by 27%, and modestly reduce
blood pressure and C-reactive protein thereby modifying the
cardiovascular risk proﬁle of patients after only 30 days [56].
Recent clinical studies have provided new evidence on
Danshen, a commonly used herbal medicine for CVD in
China, which may have a similar eﬃcacy to the known NO
donor nitroglycerin [57–59]. The extract of Salviae Miltior-
rhiae, or Danshen in Chinese, contains large amounts of
nitrate [32]. The demonstration of beneﬁcial eﬀects of this
herb on ischemic diseases oﬀers an alternative avenue for the
management of angina pectoris, myocardial infarction, or
stroke [60, 61]. Danshen-related Chinese herbal medicines
have been widely used for treatment of coronary heart dis-
easeintheEast,andaclinicaltrialisonthewayintheUnited
States. Danshen is a routine herbal medication for acute
angina pectoris. In addition, it may be eﬀective for dyslipi-
demia, blood hyperviscosity syndrome, peripheral angiopa-
thy (superﬁcial thrombophlebitis, venous thrombosis, aller-
gic arteriolitis), diabetes mellitus, and cirrhosis and is also
used for altitude sickness. Experimental studies have shown
that Danshen dilates coronary arteries, increases coronary
blood ﬂow, and scavenges free radicals in ischemic diseases,
reducingcellulardamagefromischemiaandimprovingheart
functions, remarkably similar to known eﬀects of NO and
nitrite [59]. However, the nitrate/nitrite reductase activity
in Danshen is relatively low. Often, Danshen is mixed with
other herbal products. One of which is an extract of cinna-
mon or borneol. Borneol is consumed excessively in China
and Southeast Asian countries, particularly in a combined
formula for preventing cardiovascular disease. Borneol
exertsaconcentration-dependentinhibitoryeﬀectonvenous
thrombosis[62].Theantithromboticactivityofborneolcon-
tributestoitsactionincombinedformulaforpreventingcar-
diovascular diseases. Our recent studies have shown that
although the natural form of borneol itself contains very
little nitrite and nitrate, it displays a potent nitrite reductase
activity [32] that when used in combination with nitrite
and nitrate-rich DanShen provides the system for generating
NO. Another herbal medicine made from the root of Radix
ginseng may also have synergistic eﬀects with Danshen.
Ginsengcontainsmodestamountsofnitratebuthasstronger
reductaseactivity[32].Therefore,thismayexplainthemech-
anism behind the theory of synergy of speciﬁc combination
of herbs.
6. Effects of TCM on L-Arginine/eNOS/NO
SignalingPathway
Some TCM may regulate NO production by exerting reg-
ulatory eﬀects on the L-arginine/eNOS/NO signaling path-
way. Puerarin is a major active ingredient extracted from
the traditional Chinese medicine Ge-gen (Radix Puerariae,
RP). It has long been used to treat cardiovascular diseases in-
cluding coronary artery diseases (CAD), arrhythmia, and
hypertension. Recent studies have shown that puerarin
increases serum nitrite concentrations in rats with myocar-
dial ischemia through the induction of protein expression
and activation of eNOS and through Akt/PKB phosphoryla-
tion [63]. Tongxinluo (TXL), a mixture of traditional Chi-
nese medicines, can attenuate the no-reﬂow and ischemia-
reperfusion injury in an infarct animal model [64, 65]. TXL
is composed of Radix ginseng, Buthus martensii, Hirudo, Eu-
polyphaga seu steleophaga, Scolopendra subspinipes, Perios-
tracum cicadae, Radix paeoniae rubra, Semen ziziphi spinosae,
Lignum dalbergiae odoriferae, Lignum santali albi, and Borne-
olum syntheticum. Owing to its eﬃcacy and minimal adverse
eﬀects, TXL has been widely used in China to treat patients6 Evidence-Based Complementary and Alternative Medicine
with acute coronary syndrome. In a 90-minute ischemia and
3-hour reperfusion model, miniature pigs were randomly
assigned to treatment with TXL (gavaged 1 hour prior to
ischemia); TXL plus H-89 (protein kinase-A inhibitor intra-
venously infused before ischemia); or TXL plus N(omega)-
nitro-L-arginine (L-NNA; an eNOS inhibitor, intravenously
administered prior to ischemia). The results of this study
demonstratethatTXLtreatmentcandecreasecreatinekinase
elevation, improve coronary ﬂow, and reduce infarct size.
The eﬀects of TXL may be partially abolished by H-89
or completely reversed by L-NNA. In addition, TXL treat-
ment can elevate the kinase activity and expression, evi-
dencedbyexpressionofThr198phosphorated-PKA,Ser1179
phosphorated-eNOS (p-eNOS), and Ser635 p-eNOS in the
ischemic myocardium. Addition of H-89 diminishes the
TXL activities. Thus, pretreatment with a single low loading
dose of TXL 1 hour before ischemia reduces the myocardial
no-reﬂow phenomenon and ischemia-reperfusion injury by
upregulating the phosphorylation of eNOS at Ser1179 and
Ser635, and this eﬀect is partially mediated by the PKA
pathway[64].RecentstudiesalsohaveshownthatSalvianolic
acid B (Sal B) and Tanshinone IIA (Tan IIA) are two of
the major components in Danshen, have cardioprotective
eﬀectsinaninvivomyocardialinfarctionmodelofC57mice,
have vasodilator action in an ex vivo microartery system
through the endothelial nitric oxide synthase (eNOS)/nitric
oxide pathway, and are involved in the regulation of the
L-arginine/eNOS/NO pathways in human umbilical vein
endothelialcells(HUVECs).BothSalBandTanIIAinhibited
cardiac hypertrophy and infarction sizes and improved
cardiac function at 4 weeks after induction of infarction.
Furthermore, an eNOS inhibitor (L-NAME) obliterated the
observed eﬀects. Sal B and Tan IIA mediated vasodilatation
in mice coronaries ex vivo, the eﬀect of which was decreased
with either L-NAME or PI3K inhibitor (LY294002). In addi-
tion, Sal B and Tan IIA-induced vasodilatation was observ-
ed ex vivo in the microvessels of eNOS−/− m i c e .S a lBa n d
Tan IIA also stimulated eNOS phosphorylation in a concen-
tration-andtime-dependentmannerintheHUVECculture,
which was diminished by LY294002. In addition, Sal B
and Tan IIA were found to stimulate the phosphorylation
of AMPK (Thr(172)) and Akt (Ser(473)), while compou-
nd C signiﬁcantly decreased the phosphorylation of Akt
(Ser(473)) mediated by both. Finally, Sal B and Tan IIA were
found to induce [(3)H]-L-arginine uptake and increase the
CAT-1 and CAT-2B mRNA levels in HUVEC culture [66].
It appears that select TCM herbs alone and in combination
can restore NO homeostasis both through an endothelium
dependent manner by activating the L-arginine pathway
and through an endothelium-independent manner via the
nitrate-nitrite-NO pathway that may overcome endothelial
dysfunction.
7. Effects of CAM on OxidativeStress and
Preservation of NO Activity
In several chronic diseases, free radicals are by-products of
abnormal body metabolism and are important factors for
late complications and secondary disease especially those
related to NO and endothelial dysfunction [67]. There is in-
creasing evidence that in certain pathologic states the
increased production and/or ineﬀective scavenging of reac-
tive oxygen species (ROS) may play a critical role. Medicinal
plants are a source for a wide variety of natural antioxi-
dants [68] and my exhibit their eﬀects via several proposed
mechanisms, including inhibition of the activities of cyclo-
oxygenase-2 (COX-2) and nuclear factor-Kappa B (NF-κB),
inhibition of angiogenesis, and activation of Nrf2-mediated
antioxidant signaling [69], all known to interface with the
NO pathway. Dang Gui has been shown to hold anti-inﬂam-
matory properties and antioxidant activities, especially when
used concurrently with other herbs [70]. Dietz and col-
leagues have reported that the major lipophilic constituent
of Dang Gui, Z-ligustilide, reduces oxidative stress through
upregulation of antioxidant enzymes such as NQO1, an
Nrf2 pathway gene [71]. Also, A. sinensis can protect against
oxidant injury through elevated glutathione synthesis whose
rate limiting step is regulated by the Nrf2-regulated gene γ-
GCS [72]. Of the diﬀerent components in Dan Shen, tanshi-
none IIA has been identiﬁed with the most potent antiox-
idant activity and cytotoxic properties by inducing apo-
ptosis and diﬀerentiation in various human cancer cell lines
[73]. Tanshinone IIA also displays antioxidant protection
against reactive oxygen species (ROS) induced oxidative
stress through stress-activated kinases JNKs and p38 MAPK
and by an increase in scavenging of oxygen free radicals
[74]. Drinking tea is a tradition that began in ancient China
over 5000 years ago. Green tea from the leaves of Came-
llia sinensis is the second most consumed beverage in the
world, after water. It is a well-studied herb for its eﬀectiv-
enessinchemoprevention,cancertherapy,andotherbeneﬁts
tooverallhealth.Themaincomponentsofgreenteaarepoly-
phenols, known as catechins, which account for 30–42% of
the solid weight in green tea leaves. The most abundant
polyphenol in green tea is (−)-epigallocatechin-3-gallate
(EGCG), which is also the most commonly studied green
tea component [75]. EGCG contributes to 10–50% of the
total polyphenol contents in green tea and appears to possess
the strongest antioxidant activity, about 25–100 fold more
potent than vitamins C and E [75]. Reducing oxidative stress
and promoting endogenous antioxidant enzymatic defense
systems very likely provides an additional beneﬁt of tradi-
tional medicines. These antioxidants defenses will enhance
endogenous NO production by keeping essential cofactors
such as BH4 from becoming oxidized and also preserve and
prolong NO activity once it is produced by preventing its
scavenging by oxygen radicals.
8. Conclusion
Takentogether,theNOsignalingpathwayplaysanimportant
role in the therapeutic eﬀect of many CAMs used for cardio-
vascular disease (Figure 2). The NO donor-like herbs may
serve as an alternative source of nitrate and nitrite or other
NO-donors. They contain high activities of nitrite reductase
that converts the inorganic anion into NO, which, in turn,Evidence-Based Complementary and Alternative Medicine 7
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Figure 2: Potential mechanisms of TCM on the regulation of NO Signaling pathway TCM herbs alone and in combination can help restore
NO homeostasis in the CVD and maintain “Yin-Yang” balance through reduction of Nitrate/nitrite and oxidation of L-arginine.
relaxes blood vessels and prevents thrombosis. There are
also some TCM which contain regulatory factors that inﬂu-
ence the expression and activity of eNOS (Figure 2)a n d
may interact with endogenous factors that modulate L-
arginine/eNOS/NO signaling pathway. Modern research is
providing more evidence to understand speciﬁc activity of
CAMs that will hopefully provide a mechanistic understand-
ing of their clinical eﬃcacy and allow for better combination
of diﬀerent herbs. However, currently the use of CAM is
inﬂuencedbylegalrestrictions,withshiftstowardsincreasing
regulation and formal recognition of CAM as means to treat
or prevent disease. Further investigation and research are
warranted in terms of the functional mechanisms, biosafety,
and large-scale clinical trials to ﬁrmly establish the eﬃcacy of
many of these approaches in the prevention and treatment of
illnesses.
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